- Our Doctors
- Dr Johnathon Wake
Dr Johnathon Wake
BSc (UNSW), MBBS (Sydney), FRANZCR, Radiation Oncologist
I am committed to ensuring patients with head and neck cancer in the Albury-Wodonga region can receive high quality, evidence based treatment close to home
Languages spoken
English
Overview
Centres
Clinical interests
Clinical interests in head and neck, skin, lung, and central nervous system cancers
Dr Johnathon Wake is a consultant radiation oncologist at GenesisCare in Albury-Wodonga and Shepparton. Whilst predominantly focused on the treatment of Head and Neck Cancer, Dr Wake treats a broad range of malignancies and enjoys collaborating together in a multidisciplinary environment with other specialists, aiming to achieve the best possible clinical outcomes for patients.
Dr Wake completed his Bachelor of Science majoring in biochemistry at the University of New South Wales in 2008, followed by a postgraduate medical degree from the University of Sydney in 2012. He subsequently undertook specialty Radiation Oncology training in Westmead, Blacktown and Nepean Hospitals in Sydney, with rotations to the Chris O’Brien Lifehouse and Port Macquarie Hospitals, becoming a Fellow of the Royal Australian and New Zealand College of Radiologists in 2022. Throughout his training and in his current specialist role, Dr Wake has been active in teaching medical students.
Having grown up in rural NSW, including in Albury-Wodonga, Dr Wake is passionate about offering high-quality care to regional cancer patients, believing that patients in large regional centres should never be disadvantaged when receiving cancer treatment.
Research interests
Research interests include: breast cancer, lung cancer, sarcoma and medical education.
Professional memberships
- RANZCR
- TROG
- ASTRO
- ESTRO
Publications
- J R Wake, F Q Chen, S Ashworth, K Byth, W Wang, K E Stuart: Verification using in vivo optically stimulated luminescent dosimetry of the predicted skin surface dose in patients receiving postmastectomy radiotherapy (2021). Medical Dosimetry, 46 (2) e1-6.
- E A Connolly, V A Bhadri, J R Wake, K M Ingley, J Lewin, S Bae, D D Wong, A P Long, D Pryor, S R Thompson, M C Strach, P S Grimison, A Mahar, F Bonar, F Maclean, A Hong: Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review (2022) Cancer Medicine Online ahead of print, DOI: 10.1002/cam4.4580
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.